Mizuho raises HCA price objective to $102: 5 quick notes

Mizuho analysts raised its price objective of Hospital Corporation of America stock to $102, according to EMQ News & Analysis.

Advertisement

Here are five quick notes:

1. The analysts’ target price indicates a potential upside of nearly 47 percent from HCA’s currents price.

2. HCA has a 12-month low of $43.91 and a 12-month high of $95.49.

3. The company has a 50-day moving average of $66.29.

4. The 200-day moving average is $76.58.

5. The market cap is $27.74 billion.

More articles on surgery centers:
Morningstar gives Tenet shares ‘B’ credit rating: 5 quick facts
8 things to know about HCA’s Q4 results
DPR Construction moves forward in building Shriners for Children Medical Center’s outpatient center, includes ASC: 4 highlights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.